Literature DB >> 16882478

Prevention of postoperative infections in horses.

Elizabeth M Santschi1.   

Abstract

The best defense against postoperative infection is to use multiple strategies to minimize wound contamination, maintain wound tissue health, and provide rational antimicrobial strategies that do not promote the development of resistant bacteria and superinfections.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882478     DOI: 10.1016/j.cveq.2006.03.002

Source DB:  PubMed          Journal:  Vet Clin North Am Equine Pract        ISSN: 0749-0739            Impact factor:   1.792


  5 in total

1.  A retrospective analysis of the risk factors for surgical site infections and long-term follow-up after transpalpebral enucleation in horses.

Authors:  Tsjester Huppes; Hanneke Hermans; Jos M Ensink
Journal:  BMC Vet Res       Date:  2017-06-02       Impact factor: 2.741

2.  Comparison of incisional complications between skin closures using a simple continuous or intradermal pattern: a pilot study in horses undergoing ventral median celiotomy.

Authors:  Doreen Scharner; Claudia Gittel; Karsten Winter; Dominique Blaue; Carola Schedlbauer; Ingrid Vervuert; Walter Brehm
Journal:  PeerJ       Date:  2018-11-09       Impact factor: 2.984

3.  Use of Clinical Audits to Evaluate Timing of Preoperative Antimicrobials in Equine Surgery at a Veterinary Teaching Hospital.

Authors:  Serena Ceriotti; Roxane Westerfeld; Alvaro G Bonilla; Daniel S J Pang
Journal:  Front Vet Sci       Date:  2021-03-26

4.  Use of aminoglycoside antibiotics in equine clinical practice; a questionnaire-based study of current use.

Authors:  Adam Redpath; Gayle D Hallowell; Ian Mark Bowen
Journal:  Vet Med Sci       Date:  2020-10-24

5.  Colloidal Iron Oxide Formulation for Equine Hoof Disinfection.

Authors:  Maurizio Isola; Cristina Piccinotti; Massimiliano Magro; Luca Fasolato; Fabio Vianello; Maria Luisa Menandro; Parastoo Memarian; Melissa Rossi; Maria Elena Falomo
Journal:  Animals (Basel)       Date:  2021-03-10       Impact factor: 2.752

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.